Literature DB >> 32217073

Dyslipidemia in Type 1 Diabetes: AMaskedDanger.

Bruno Vergès1.   

Abstract

Type 1 diabetes (T1D) patients show lipid disorders which are likely to play a role in their increased cardiovascular (CV) disease risk. Quantitative abnormalities of lipoproteins are noted in T1D with poor glycemic control. In T1D with optimal glycemic control, triglycerides and LDL-cholesterol are normal or slightly decreased whereas HDL-cholesterol is normal or slightly increased. T1D patients, even with good glycemic control, show several qualitative and functional abnormalities of lipoproteins that are potentially atherogenic. An association between these abnormalities and CV disease risk has been reported in recent studies. Although the mechanisms underlying T1D dyslipidemia remain unclear, the subcutaneous route of insulin administration, that is responsible for peripheral hyperinsulinemia, is likely to be an important factor.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cardiovascular; insulin; lipids; lipoproteins; type 1 diabetes

Mesh:

Substances:

Year:  2020        PMID: 32217073     DOI: 10.1016/j.tem.2020.01.015

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  13 in total

1.  A Modern Approach to Dyslipidemia.

Authors:  Amanda J Berberich; Robert A Hegele
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

2.  Silymarin from Milk Thistle Fruits Counteracts Selected Pathological Changes in the Lenses of Type 1 Diabetic Rats.

Authors:  Weronika Borymska; Maria Zych; Sławomir Dudek; Ilona Kaczmarczyk-Sedlak
Journal:  Nutrients       Date:  2022-03-30       Impact factor: 5.717

3.  Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial.

Authors:  Naba Al-Sari; Signe Schmidt; Tommi Suvitaival; Min Kim; Kajetan Trošt; Ajenthen G Ranjan; Merete B Christensen; Anne J Overgaard; Flemming Pociot; Kirsten Nørgaard; Cristina Legido-Quigley
Journal:  Endocrinol Diabetes Metab       Date:  2021-01-04

4.  Dyslipidemia Among Patients With Type 1 Diabetes and Its Associated Factors in Saudi Arabia: An Analytical Cross-Sectional Study.

Authors:  Abdullah A Alrasheed
Journal:  Cureus       Date:  2022-02-05

5.  Evaluation of Oxidative Stress Biomarkers, Pro-Inflammatory Cytokines, and Histological Changes in Experimental Hypertension, Dyslipidemia, and Type 1 Diabetes Mellitus.

Authors:  Paul-Mihai Boarescu; Ioana Boarescu; Raluca Maria Pop; Ştefan Horia Roşian; Ioana Corina Bocșan; Vasile Rus; Răzvan Olimpiu Mada; Iulia Diana Popa; Nicholas Neagu; Adriana Elena Bulboacă; Anca Dana Buzoianu; Sorana D Bolboacă
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

6.  Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression.

Authors:  Jiayi Xiang; Huifang Zhang; Xingcheng Zhou; Dan Wang; Rongyu Chen; Wanlin Tan; Luqun Liang; Mingjun Shi; Fan Zhang; Ying Xiao; Yuxia Zhou; Yuanyuan Wang; Bing Guo
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

Review 7.  HDL functionality in type 1 and type 2 diabetes: new insights.

Authors:  M John Chapman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-04-01       Impact factor: 3.243

8.  Risk factors for nephropathy in persons with type 1 diabetes: a population-based study.

Authors:  Shilan Seyed Ahmadi; Aldina Pivodic; Ann-Marie Svensson; Hans Wedel; Björn Rathsman; Thomas Nyström; Johnny Ludvigsson; Marcus Lind
Journal:  Acta Diabetol       Date:  2022-02-24       Impact factor: 4.087

9.  Comorbidities in Recent-Onset Adult Type 1 Diabetes: A Comparison of German Cohorts.

Authors:  Oana P Zaharia; Stefanie Lanzinger; Joachim Rosenbauer; Wolfram Karges; Karsten Müssig; Sebastian M Meyhöfer; Volker Burkart; Michael Hummel; Dirk Raddatz; Michael Roden; Julia Szendroedi; Reinhard W Holl
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

10.  Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles.

Authors:  Antonio J Amor; Esmeralda Castelblanco; Marta Hernández; Marga Gimenez; Minerva Granado-Casas; Jesús Blanco; Berta Soldevila; Enric Esmatjes; Ignacio Conget; Nuria Alonso; Emilio Ortega; Didac Mauricio
Journal:  Cardiovasc Diabetol       Date:  2020-08-09       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.